SVCM
Saturn V Capital Management’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-71,463
| Closed | -$4.2M | – | 27 |
|
|
2024
Q1 | $4.2M | Sell |
71,463
-71,464
| -50% | -$4.2M | 1.68% | 18 |
|
|
2023
Q4 | $8.56M | Buy |
+142,927
| New | +$8.56M | 3.27% | 13 |
|
|
2023
Q3 | – | Sell |
-107,406
| Closed | -$9.78M | – | 21 |
|
|
2023
Q2 | $9.78M | Sell |
107,406
-15,759
| -13% | -$1.44M | 5.43% | 9 |
|
|
2023
Q1 | $8.12M | Sell |
123,165
-89,164
| -42% | -$5.88M | 6.07% | 11 |
|
|
2022
Q4 | $9.41M | Buy |
+212,329
| New | +$9.41M | 7.81% | 3 |
|